World ADC London

March 12-15, 2024, London, United Kingdom

If you're planning to attend World ADC London this year, be sure to stop by booth #24 to meet the Merck team. Ask us about our expertise in conjugating drug linkers to monoclonal antibodies and the benefits it can bring to your project. Additionally, learn about our specialized facilities tailored for handling highly potent compounds.

Discover how our Millipore^® CTDMO Services can support you in effectively bringing your drug to market.

Don't miss our presentations

March 13

• Demonstrating Technical Excellence in ADCs from preclinical development to commercial manufacturing - Scientific Programme

March 14

• Lunch and Learn with Merck - From Molecule to Market: Comprehensive CDMO Services for ADC and Bioconjugation - Scientific Programme

Related Technical Content

ADC & Bioconjugation Contract Testing, Development, & Manufacturing Services
Antibody-Drug Conjugate (ADC) Manufacturing
What is an Antibody-Drug Conjugate?
Simplifying Antibody-Drug Conjugate Payload Synthesis Using Payload Intermediates
Improving Antibody-drug Conjugate (ADC) Solubility with Hydrophobic Novel Payloads Using the Chito-oligosaccharide ChetoSensar^™